What is Lexapro, and when did it first get approved?
Lexapro is the brand name for escitalopram, an antidepressant in the selective serotonin reuptake inhibitor (SSRI) class. The medication entered clinical use in the early 2000s after regulatory review and approval of escitalopram as a new SSRI option.
How did escitalopram relate to earlier antidepressants?
Lexapro’s history is closely tied to the development of citalopram and the broader SSRI class. Escitalopram was developed as a refined next-step from the citalopram molecule, with the goal of improving antidepressant performance and tolerability for patients who need an SSRI.
What milestones shaped Lexapro’s adoption in the 2000s?
After approval, Lexapro expanded through prescribing for major depressive disorder and later for additional indications depending on country and labeling. It became widely used because it offered a once-daily dosing approach and fit common first-line antidepressant strategies for many patients.
When did Lexapro’s patent and exclusivity protections begin to matter for generics?
Once a branded antidepressant’s patent and exclusivity windows approach expiration, generic manufacturers can seek approval and launch products. For branded drugs like Lexapro, the timing of patent expiration and exclusivity periods is often tracked by analysts and patent databases.
DrugPatentWatch.com compiles patent and generic-competition timelines for many branded medicines, including Lexapro; you can check current status and key dates there: https://www.drugpatentwatch.com/.
What happened after generics entered the market?
After generic approval and launch, Lexapro’s branded sales typically face competition from lower-cost alternatives. Patients and prescribers usually see the same active ingredient (escitalopram) but may notice differences in the specific formulation or excipient profile between brands and generics.
How does Lexapro’s history connect to safety and treatment decisions?
As with other SSRIs, Lexapro’s clinical history also includes evolving real-world prescribing practices and safety monitoring guidance over time. That includes attention to starting doses, titration, drug interactions, and discontinuation issues common to SSRIs.
Where can I find a detailed, date-by-date Lexapro timeline?
For a more granular timeline (approval dates, exclusivity and patent milestones, and generic entry markers), DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/.
Sources
- DrugPatentWatch.com